Henry Schein, Inc. (NASDAQ:HSIC) Updates FY17 Earnings Guidance
Henry Schein, Inc. (NASDAQ:HSIC) updated its FY17 earnings guidance on Tuesday. The company provided earnings per share guidance of $7.17-7.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.29.
A number of research analysts have recently weighed in on the stock. Barrington Research raised their price objective on shares of Henry Schein from $196.00 to $198.00 and gave the stock an outperform rating in a research note on Wednesday, May 10th. Zacks Investment Research raised shares of Henry Schein from a hold rating to a buy rating and set a $204.00 price objective for the company in a research note on Thursday, May 25th. Credit Suisse Group reaffirmed a hold rating and issued a $160.00 target price on shares of Henry Schein in a research note on Thursday, July 13th. Craig Hallum assumed coverage on shares of Henry Schein in a research note on Tuesday, April 11th. They issued a hold rating for the company. Finally, Stifel Nicolaus lifted their target price on shares of Henry Schein from $174.00 to $178.00 and gave the stock a hold rating in a research note on Wednesday, May 10th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have given a buy rating to the company. The stock presently has an average rating of Hold and a consensus price target of $185.56.
Henry Schein, Inc. (HSIC) opened at 183.79 on Tuesday. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $186.99. The firm has a market cap of $14.58 billion, a price-to-earnings ratio of 27.93 and a beta of 1.09. The company’s 50 day moving average is $183.44 and its 200 day moving average is $174.47.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 8th. The company reported $1.75 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.01. The firm had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a net margin of 4.53% and a return on equity of 19.74%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.64 EPS. On average, equities analysts anticipate that Henry Schein, Inc. will post $7.29 earnings per share for the current year.
In other Henry Schein news, EVP Gerald A. Benjamin sold 12,578 shares of the business’s stock in a transaction that occurred on Thursday, May 11th. The shares were sold at an average price of $175.10, for a total value of $2,202,407.80. Following the completion of the sale, the executive vice president now directly owns 44,061 shares of the company’s stock, valued at $7,715,081.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.27% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.